Gustavo E. Velásquez

Also affiliated with University of California System, Office of Infectious Diseases, Global Brain Health Institute, Global Solutions for Infectious Diseases

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial”.

Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(25)00194-8

N/A

0.781DataRank · unranked

26 citations

Uzma Khan, Gustavo E. Velásquez, Maëlenn Gouillou, Muhammad Hammad Ali, Samreen Amjad +95 more

Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa415

N/A

0.590DataRank · unranked

50 citations

Brandon Dionne, Aaron Richterman, Samuel J. Vidal, Zoe Weiss, Gustavo E. Velásquez +4 more

Standards for clinical trials for treating TB

The International Journal of Tuberculosis and Lung Disease(2023)10.5588/ijtld.23.0341

N/A

0.471DataRank · unranked

5 citations

Jane Greig, J.-W. C. Alffenaar, Gail Brenda Cross, C. R. Cousins, Catherine Berry +35 more

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis

Clinical Infectious Diseases(2024)10.1093/cid/ciae119

N/A

0.306DataRank · unranked

6 citations

Ava Y Xu, Gustavo E. Velásquez, Nan Zhang, Vincent Chang, Ekaterina V. Kurbatova +16 more

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Market and City Bus Depot Workers in Lima, Peru

Clinical Infectious Diseases(2021)10.1093/cid/ciab323

N/A

0.208DataRank · unranked

3 citations

Jesús Peinado, Santiago Palomino, Fernando Llanos, Claudio Carpio Ramírez, Gisella Valderrama +7 more

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis

Trials(2025)10.1186/s13063-025-08973-w

N/A

0.168DataRank · unranked

2 citations

Gustavo E. Velásquez, Russell R. Kempker, Marjorie Z. Imperial, Eric L. Nuermberger, Susan E. Dorman +22 more

Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad320

N/A

0.104DataRank · unranked

1 citations

Marco Tovar, Jesús Peinado, J. Santiago Palomino, Claudio C. Ramı́rez, Fernando Llanos-Zavalaga +11 more

Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf195

N/A

0.104DataRank · unranked

1 citations

Gareth Platt, Charles A. Peloquin, M B Brooks, Julia Coit, Gustavo E. Velásquez +12 more

Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trial

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.107875

N/A

0.104DataRank · unranked

1 citations

Lelia H. Chaisson, Zana Wangari Kiragu, Praewpannarai Buddadhumaruk, Ariana Austin, Yilan Gao +16 more

SARS-CoV-2 Testing Disparities in Massachusetts

medRxiv(2020)10.1101/2020.11.02.20224469

N/A

0DataRank · unranked

6 citations

Gustavo E. Velásquez, Thomas J. Stopka, Sonya Davey, Shahin Lockman, Bisola O. Ojikutu +1 more

Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case Report

Open Forum Infectious Diseases(2020)10.1093/ofid/ofaa077

N/A

0DataRank · unranked

8 citations

Leela Davies, Amir M. Mohareb, Paula M. Peçanha‐Pietrobom, Nirav J. Patel, Isaac H. Solomon +7 more

Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures

medRxiv(2025)10.1101/2025.07.25.25332013

N/A

0DataRank · unranked

0 citations

Gustavo E. Velásquez, John D. Szumowski, Allison L. Phillips, Annie Kim, Jinoos Yazdany +8 more

Tuberculosis Infection Screening Recommendations for Targeted Immunotherapies: Comparison of US Prescribing Information, Clinical Resources, and Quality Measures

Clinical Infectious Diseases(2025)10.1093/cid/ciaf628

N/A

0DataRank · unranked

1 citations

Gustavo E. Velásquez, John D. Szumowski, Allison L. Phillips, Annie Kim, Jinoos Yazdany +8 more

Recent advances in the treatment of tuberculosis

Clinical Microbiology and Infection(2023)10.1016/j.cmi.2023.07.013

N/A

0DataRank · unranked

117 citations

Martin J. Boeree, Dumitru Chesov, Keertan Dheda, Gunar Günther, C. Robert Horsburgh +13 more

Disparities in SARS-CoV-2 Vaccination-to-Infection Risk, Massachusetts 2020-2021

medRxiv(2021)10.1101/2021.04.14.21255467

N/A

0DataRank · unranked

1 citations

Gustavo E. Velásquez, Thomas J. Stopka, Sonya Davey, Rajesh T. Gandhi, Shahin Lockman +2 more